skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: In vivo studies of branched chain fatty acids

Technical Report ·
OSTI ID:5767405

Studies using (1-C-11)-3-methylheptadecanoic acid (BMHDA) have been performed both in animals and man to define the characteristics of the agent. Evaluation of BMHDA as a myocardial imaging agent in anesthetized dogs revealed blood clearance half times of less than 2 minutes accompanied by prompt myocardial concentration. Within 2 minutes the myocardium could be delineated, Plateau myocardial concentration of 3 to 4% of the injected dose was observed. This value persisted for intervals up to 70 minutes. In addition to the heart, the liver was the only other organ clearly delineated. The prompt concentration of fatty acid in the myocardium and the rapid blood clearance raised the spectre that the fatty acids may behave as Sapirstein tracers in the myocardium - i.e., their distribution may be dominated by regional perfusion and, thereby, make these agents less useful as independent indicators of myocardial metabolism. The effects of severe chronic hypertension of myocardial uptake of BMHDA was studied. These experiments were designed to define whether the myocardium continues to utilize fatty acids as a major substrate when myocardial work is excessive. 7 refs.

Research Organization:
Massachusetts Inst. of Tech., Cambridge (USA)
DOE Contract Number:
FG02-86ER60460
OSTI ID:
5767405
Report Number(s):
DOE/ER/60460-T1; ON: DE88002585
Resource Relation:
Other Information: Portions of this document are illegible in microfiche products
Country of Publication:
United States
Language:
English

Similar Records